共 18 条
[1]
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: Results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers
[J].
JOURNAL OF CLINICAL PHARMACOLOGY,
2008, 48 (04)
:418-427
[2]
Bariatric surgery: A systematic review and meta-analysis
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2004, 292 (14)
:1724-1737
[3]
Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725
[7]
Discovery of 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8-(5H)-one (PF-514273), a Novel, Bicyclic Lactam-Based Cannabinoid-1 Receptor Antagonist for the Treatment of Obesity
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
2009, 52 (09)
:2652-2655
[10]
FELDER CC, 1995, MOL PHARMACOL, V48, P443